First National Corporation Reports SECOND Quarter 2026 FINANCIAL PERFORMANCE

FIRST NATIONAL CORP /VA/ (FXNC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 First National Corporation Reports SECOND Quarter 2026 FINANCIAL PERFORMANCE STRASBURG, Va., July 29, 2026 --- First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported consolidated ne

Event · Earnings
Also in this documentDividend · $0.17

Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.

Original reporting
Published Jul 29, 2026, 1:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 1:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$FXNC
Bullish
medium confidence
Mentioned
$FXNC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FXNCBullishMed
01

Why it matters

Traders can update expectations for near-term earnings power using the reported NIM, loan growth, and credit metrics, and also model the timing of a potential one-time gain tied to the North Carolina branch sale expected to close early in Q4.

02

Market read

Q2 performance shows higher EPS and NIM with stable asset quality, while regulatory approvals for the branch sale increase the probability of a Q4 closing and potential one-time gain.

03

What to watch

The filing notes acquisition-accounting accretion impacts NIM and a planned one-time gain from the branch sale in Q4, which may not recur and could distort forward earnings expectations.

Relevance 7/10Novelty 6/10Timing: after-hours filing of Q2 2026 results and branch-sale regulatory approvals

Background

This is an SEC Form 8-K with Exhibit 99.1 covering First National Corporation’s Q2 2026 financial results and updates on its branch optimization initiative.

Company-level read

Ticker impact

$FXNCBullishMedium confidence
Context

First National Corporation reported Q2 2026 net income of $5.7M and EPS of $0.64, plus a 4.15% tax-equivalent NIM and $22.7M net loan growth.

Expected impact

Likely modest positive bias for near-term trading as investors weigh higher NIM/EPS and sound credit against higher noninterest expense and the timing of the branch-sale gain.

Evidence & confidence

The filing provides multiple directionally favorable operating metrics (EPS up YoY, NIM up, non-performing assets at 0.23%) and confirms regulatory approvals for the North Carolina branch sale expected to close early in Q4, which can support sentiment even without explicit guidance.

Market effects

Adds datapoint on small-bank profitability drivers (NIM expansion, expense management) and credit stability.

Highlights ongoing branch optimization in Virginia/North Carolina footprint, potentially affecting local deposit/loan flows.

Limited, as it is a single regional bank holding company filing.

Counterpoint

Noninterest expense rose quarter over quarter and the credit provision was still material, so the EPS improvement may be more mix-driven than durable.

Key entities

  • First National Corporation

    NASDAQ-listed bank holding company reporting Q2 2026 results and progress on a pending North Carolina branch sale.

  • First Bank

    Operating bank referenced as the entity conducting the branch optimization and sale.

  • Scott C. Harvard

    President and CEO quoted on strategy execution, NIM, asset quality, and regulatory approvals for the branch sale.

Related articles

$FXNCMed

First National Corporation Reports Second Quarter 2026 Financial Performance

First National Corporation (NASDAQ: FXNC) reported Q2 2026 net income of $5.7 million and EPS of $0.64 basic and $0.63 diluted for the quarter ended June 30, 2026. Results included net interest margin of 4.15% FTE, net interest income of $20.1 million, and a $426k credit loss provision. The company said regulatory approvals were received for a pending sale of North Carolina branches expected to close in early Q4 2026.

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.